ICU

• 2026-07-01 share offering or dilution eventfreshOpen filing ↗
  “…CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))…”
• 2026-06-17 share offering or dilution eventfreshOpen filing ↗
  “…CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities…”
• 2026-06-17 reverse splitfreshOpen filing ↗
  “…have been duly elected and qualified: Nominee Votes For Votes Against Abstentions Broker Non-Votes John Neuman 757,141 23,212 4,829…”
  +1 more passage from the same document

  • “…shall have been duly elected and qualified: Nominee Votes For Votes Against Abstentions Broker Non-Votes John Neuman 757,141…”
• 2026-05-13 share offering or dilution eventrecentOpen filing ↗
  “…such funds effectively could have a material adverse effect on our business, financial condition, operating results and cash flows.…”
  +1 more passage from the same document

  • “…We have used at-the-market, or ATM, offerings to fund a significant portion of our operations in prior years, and we may…”
• 2026-05-13 reverse splitrecentOpen filing ↗
  “…for one share of Common Stock for $11.50 per share (the “Listed Warrants”) are traded on the Nasdaq Stock Market under the symbols…”
  +1 more passage from the same document

  • “…Stock for $11.50 per share (the “Listed Warrants”) are traded on the Nasdaq Stock Market under the symbols “ICU” and “ICUCW,”…”
• 2026-05-13 share offering or dilution eventrecentOpen filing ↗
  “…approximately 18,880 shares of the Company's Common Stock. Note 8. Warrants The Company issued warrants in connection with…”
  +1 more passage from the same document

  • “…Common Stock. During the three months ended March 31, 2026, the Company raised $ 0.3 million, net of offering costs of…”
• 2026-05-13 listing compliance noticerecentOpen filing ↗
  “…notwithstanding Nasdaq Listing Rule 5810(c)(2), we would not be permitted to provide the Staff with a plan of compliance with…”
  +1 more passage from the same document

  • “…5810(c)(3). Instead, the Staff would issue a “Delist Determination Letter” and we would have an opportunity to request a new…”
• 2026-05-13 reverse splitrecentOpen filing ↗
  “…year ended December 31, 2025 . The interim unaudited condensed consolidated financial statements include the consolidated accounts of…”
  +1 more passage from the same document

  • “…owned subsidiary, SeaStar Medical, Inc. All significant intercompany transactions have been eliminated in consolidation. On June…”

1 older entry not shown

Recorded SEC filings in plain language — not advice or a prediction.